Metraipolis › archive › dc_5a51dfde8fbe
Health-related quality of life with encorafenib plus binimetinib for BRAF V600E thyroid cancer — Europe PMC PMID:41885282
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41885282
- DOI
- 10.1530/etj-25-0273
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T09:49:47.882Z
- SHA-256 of the archived text
0f9af068e23cfc198fde14a659aa3c55a2403a8fd441c87c4523012c61611432- Stable URL of this page
https://metraipolis.com/documento/dc_5a51dfde8fbe
How to cite
Health-related quality of life with encorafenib plus binimetinib for BRAF V600E thyroid cancer — Europe PMC PMID:41885282 — Europe PMC (en), https://europepmc.org/article/MED/41885282 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5a51dfde8fbe (Metraipolis archive dc_5a51dfde8fbe, sha256 0f9af068e23cfc198fde14a659aa3c55a2403a8fd441c87c4523012c61611432)
BibTeX
@misc{dc5a51dfde8fbe,
title = {Health-related quality of life with encorafenib plus binimetinib for BRAF V600E thyroid cancer — Europe PMC PMID:41885282},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41885282},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5a51dfde8fbe; sha256 0f9af068e23cfc198fde14a659aa3c55a2403a8fd441c87c4523012c61611432},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41885282. Agents can read the archived copy with the MCP tool read_document.